Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

OBJECTIVE: To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS). METHODS: Patients with probable laboratory-supported, probable or definite ALS were enrolled by 25 Italian centres and randomly assigned (1:1) to receive intravenous rhEPO 40 000 IU...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauria, Giuseppe, Dalla Bella, Eleonora, Antonini, Giovanni, Borghero, Giuseppe, Capasso, Margherita, Caponnetto, Claudia, Chiò, Adriano, Corbo, Massimo, Eleopra, Roberto, Fazio, Raffaella, Filosto, Massimiliano, Giannini, Fabio, Granieri, Enrico, La Bella, Vincenzo, Logroscino, Giancarlo, Mandrioli, Jessica, Mazzini, Letizia, Monsurrò, Maria Rosaria, Mora, Gabriele, Pietrini, Vladimiro, Quatrale, Rocco, Rizzi, Romana, Salvi, Fabrizio, Siciliano, Gabriele, Sorarù, Gianni, Volanti, Paolo, Tramacere, Irene, Filippini, Graziella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Neuromuscular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515982/
https://www.ncbi.nlm.nih.gov/pubmed/25595151
http://dx.doi.org/10.1136/jnnp-2014-308996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515982/
https://www.ncbi.nlm.nih.gov/pubmed/25595151
http://dx.doi.org/10.1136/jnnp-2014-308996

Ejemplares similares